These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 241111)
41. Efficacy and withdrawal of two potent benzodiazepines: bromazepam and lorazepam. Fontaine R; Annable L; Beaudry P; Mercier P; Chouinard G Psychopharmacol Bull; 1985; 21(1):91-2. PubMed ID: 2858908 [No Abstract] [Full Text] [Related]
42. [Treatment of depressive disorders. Clinical evaluation of the relative effectiveness of flupenthixol in comparison with bromazepam]. Paulmann F Fortschr Med; 1986 Mar; 104(10):218-22. PubMed ID: 2870960 [No Abstract] [Full Text] [Related]
43. [Clinical experiences with a new selective antispastic derivative of anisotropine]. Vignola D; Galvani A Clin Ter; 1968 Oct; 47(2):175-85. PubMed ID: 5755355 [No Abstract] [Full Text] [Related]
45. [Treatment of general psychovegetative disorders with a single night dose of dipotassium-clorazepate within a multicenter study (author's transl)]. Bentel HU; Schoenemeyer J Wien Klin Wochenschr Suppl; 1978; 92():1-7. PubMed ID: 31036 [TBL] [Abstract][Full Text] [Related]
46. [Bromazepam in the treatment of anxiety in nephrology and haemodialysis (author's transl)]. Schohn D; Schmitt R; Jahn H Nouv Presse Med; 1982 May; 11(22):1718-21. PubMed ID: 6124941 [TBL] [Abstract][Full Text] [Related]
51. [Multicenter study on the effectiveness and tolerance of a bromazepam + propantheline combination in patients with irritable bowel syndrome]. Dioguardi N; Agape D; Antoniozzi F; Ballarin E; De Franchis R; Ferrari A; Fesce E; Grimoldi D; Pozzi M; Psilogenis M Minerva Dietol Gastroenterol; 1987; 33(2):155-67. PubMed ID: 2888056 [No Abstract] [Full Text] [Related]
52. [Gefarnax in the treatment of gastrointestinal diseases of psychosomatic origin]. Bianchi A; Scanni A; Giorgi-Conciato M Minerva Gastroenterol; 1972; 18(3):175-81. PubMed ID: 4614115 [No Abstract] [Full Text] [Related]
54. [Treatment of anxiety with bromazepam in clinical practice (author's transl)]. Bornstein S; Benoudich H; Kaufman E; Konqui M; Pigeon P Nouv Presse Med; 1982 May; 11(22):1731-4. PubMed ID: 6124945 [TBL] [Abstract][Full Text] [Related]
55. [Clinical experiences with the benzodiazepine derivative bromazepam in acute agitation and excitement conditions in psychiatry]. Gsell S Nervenarzt; 1975 Aug; 46(8):463-6. PubMed ID: 4740 [No Abstract] [Full Text] [Related]
57. [Leading symptom of anxiety and tension and its concomitant somatic manifestations. A multicenter trial of fluspirilene versus bromazepam]. Thilmann J Fortschr Med; 1983 Oct; 101(37):1676-8. PubMed ID: 6139327 [TBL] [Abstract][Full Text] [Related]
58. [Comparison of bromazepam and lorazepam in the treatment of neurotic depression]. Ravenna C Clin Ter; 1980 Oct; 95(2):147-56. PubMed ID: 6110507 [No Abstract] [Full Text] [Related]
59. [Value of oral premedication with a non-sedative anxiolytic agent for performing electrophysiological hearing tests. Apropos of 100 cases of patients treated with bromazepam]. Portmann M; Négrevergne M; Chène C; Cros AM; Paty J; Berthomieu J Rev Laryngol Otol Rhinol (Bord); 1988; 109(2):155-9. PubMed ID: 2900545 [No Abstract] [Full Text] [Related]